Neogenomics (NEO) Non-Current Deferred Tax Liability (2013 - 2026)
Neogenomics' (NEO) quarterly Non-Current Deferred Tax Liability came in at $16.8 million in Q2 2026, down 15.78% YoY from $20.0 million in Q2 2025, and down 3.59% on a QoQ basis from $17.4 million in Q1 2026.
Neogenomics (NEO) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends
Neogenomics (NEO) has 14 years of Non-Current Deferred Tax Liability data on file, last reported at $16.8 million in Q2 2026.
- Quarterly Non-Current Deferred Tax Liability fell 15.78% year-over-year to $16.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $16.8 million (down 15.78% YoY) and the FY2025 annual result came in at $18.2 million, down 82.33% from the prior year.
- Non-Current Deferred Tax Liability fell to $16.8 million in Q2 2026, from $17.4 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $129.6 million in Q4 2022 to a low of $16.8 million in Q2 2026.
- A 5-year average of $42.0 million and a median of $24.4 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability soared 2864.97% — and 2025, when it sank 82.33%.
- Tracing NEO's Non-Current Deferred Tax Liability over 5 years: stood at $129.6 million in 2022, then dropped by 8.63% to $118.4 million in 2023, then retreated by 12.89% to $103.1 million in 2024, then slumped by 82.33% to $18.2 million in 2025, then fell by 7.66% to $16.8 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $16.8 million (Q2 2026), $17.4 million (Q1 2026), and $18.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.82 Mn |
| Jun 30, 2026 | 16.82 Mn |
| Mar 31, 2026 | 17.45 Mn |
| Mar 31, 2026 | 17.45 Mn |
| Dec 31, 2025 | 18.22 Mn |
| Dec 31, 2025 | 18.22 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Sep 30, 2025 | 20.85 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Jun 30, 2025 | 19.98 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Mar 31, 2025 | 20.97 Mn |
| Dec 31, 2024 | 103.11 Mn |
| Dec 31, 2024 | 103.11 Mn |
| Sep 30, 2024 | 22.77 Mn |
| Sep 30, 2024 | 22.77 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Mar 31, 2024 | 23.49 Mn |
| Mar 31, 2024 | 23.49 Mn |